Evidence For COVID-19 Vaccine Deferred Dose 2 Boost Timing

@article{Epperly2021EvidenceFC,
  title={Evidence For COVID-19 Vaccine Deferred Dose 2 Boost Timing},
  author={D. E. Epperly},
  journal={Social Science Research Network},
  year={2021}
}
  • D. Epperly
  • Published 11 January 2021
  • Medicine
  • Social Science Research Network
Both Pfizer and Moderna vaccine trials used accelerated methods to achieve rapid FDA approval with minimal and wise compromises. While many established vaccines use boost / dose 2 timings that are typically in the 3 to 120 months range , dose 2 timings for both trials were less than 30 days as part of a crucial effort to rapidly develop a vaccine with significant efficacy. Data from both trials showed excellent dose 1 efficacy; however, neither of the related Safety and Efficacy publications… 
2 Citations
Proposed Model and Approach to Graduate Mentorship and Supervision During COVID-19
Before COVID-19, post-secondary learning was dominated by in-person, institution-organized meetings. With the March 12, 2020 lockdown, learning became virtual, largely dependent on commercial online
Improving Mentorship and Supervision during COVID-19 to Reduce Graduate Student Anxiety and Depression Aided by an Online Commercial Platform Narrative Research Group
Before COVID-19, post-secondary learning was dominated by in-person, institution-organized meetings. With the 12 March 2020 lockdown, learning became virtual, largely dependent on commercial online